January
Platinum’s Andrew Clifford shorts Trump bump 2.0
The Platinum co-founder’s multibillion-dollar hedge fund is taking aim at rush to US tech stocks sparked by the president’s return to the White House.
- Joshua Peach
December 2024
Platinum suffers $840m outflows in big blow to turnaround plans
The prominent equities investment house said one institutional investor had pulled $537 million as it disclosed its November funds figures.
- Kylar Loussikian
November 2020
The Moderna way to profit from CSL's vaccine challengers
Why the technology behind Moderna's vaccine stands to disrupt CSL and how the spectacular collapse of Theranos exemplifies the need for biotech investors to always check the facts.
- Luke Housego
August 2020
Market conditions recall late 1990s 'blow-off'
Prices are loaded with danger and only a few stocks are holding the bull market together, warns Platinum's Andrew Clifford.
- Vesna Poljak
May 2020
The two things Kerr Neilson fears in pandemic
The fund manager knows his way through a crisis. This time he’s afraid of only two things: unlisted asset valuations and strongmen promises.
- Vesna Poljak